Farhad Naseh, MD Sara Tavassoli, OD
Ghada Orkubi, MD Tamara Mendez, OD
Call Today
(301) 840-2208
Office Hours:
Monday - Friday: 8:00 - 5:00
Educational Multimedia
Make an Appointment
Order Contact Lenses
Evaluate Your Visit
On-line Promotions!
Languages We Speak
Arabic, Chinese, Persian, Russian, Spanish, Tagalog, Tamil, French, Creole, Turkish and of course English


At Maryland Eye Institute we are committed to provide our patients with the most comprehensive eye care. One aspect of great eye care is technology. We place at your service the best technology in eye diagnostic available today. During your consultation our doctors will inform you about your need to receive these preventive tests. Most health insurance providers cover these diagnostic tests. A comprehensive eye and vision examination at Maryland Eye Institute may include, but is not limited to the following tests:

ReLACS™ - Custom, blade-free, Laser Assisted Cataract Surgery
It's called ReLACS, or Refractive Laser Assisted Cataract Surgery and like LASIK, it brings a new standard of precision to cataract surgery. This custom, blade-free, laser assisted cataract removal option allows us to plan and perform cataract surgeries to exacting, individualized specifications unattainable with standard cataract surgery. Click here to learn more>>>

The Maryland Eye Institute is the first center in the region to offer ReLACS, a revolutionary new laser technology to make cataract surgery more precise than ever before. This new laser cataract option, combined with one of our advanced intraocular lenses, may also restore your near and distance vision without relying on glasses, contacts, or even reading glasses. The Maryland Eye Institute is proud to now offer laser precision in cataract surgery.

Cataract surgery is the most commonly performed surgery in the United States. And with the first wave of baby boomers turning 65, the number people suffering from decreased vision due to cloudy lenses, or cataracts, is only expected to grow. That's why a new technology, offered by The Maryland Eye Institute, is so exciting.

Measuring for Most Accurate IOL Power with the Zeiss IOL Master
More than 21 million Americans age 40 and older are affected by cataract, which cloud the lens of the eye and cause vision to become blurry. When patients first come to our practice with complaints of blurry vision, they are eager to quickly correct the issue and resume their normal daily activities. This may simply mean new glasses are required, or if the cataract is significant enough, then surgery would be necessary. The Zeiss IOL Master 500 is the latest advancement in IOL calculations, because it takes into consideration and measures the varying parameters that are most important to know in order to be confident in the determination of the IOL power. This becomes even more critical when one is contemplating having a premium IOL inserted, which allows Dr. Naseh to select the best IOL for your visual expectations after cataract surgery.

Some of the advancements that the ZEISS IOL Master provides are more accurate corneal curvature measurements, a more accurate measurement of where the IOL will be positioned in the eye, as well as the overall length of the eye; all of these combine to create a more predictable and satisfactory visual outcome for the patient.

SLT Laser Therapy
SLT (Selective Laser Trabeculoplasty) is a safe and simple in-office laser treatment that effectively reduces eye pressure for most patients with glaucoma. SLT can be an effective adjunct to medication therapy or used as a primary treatment to thousand of dollars in prescription medication costs and improve compliance.

SLT Laser surgery treats the area of the eye called the trabecular meshwork. The trabecular meshwork is the area surrounding the iris that allows for free-flow and drainage of the eye fluid. With SLT, the laser works at low levels to keep the trabecular meshwork canals intact, stimulating it, thus only treating the damaged tissue and causing less trauma to the eye than traditional laser surgery for glaucoma.

Maryland Eye Institute specializes in glaucoma and SLT laser surgeries. Glaucoma is a silent, progressive disease, and is a leading cause of blindness, so it�s important to protect yourself against it. At Maryland Eye Institute, we take great care in monitoring our patients for this disease, and if diagnosed, be assured, we�ll take the greatest care with you individual vision health and recommend the best options for the glaucoma treatment that fits you needs.

Optical Coherence Tomography (OCT)
With the new FastTrac retinal tracking system, precise macular thickness analyses, Fovea Finder�, detailed layer maps and more than 100 B-scans at your disposal, OCT test provides the framework to comprehensively assess our patient�s retinal condition through a non-invasive imaging technology. OCT data cubes are registered with data from prior visits after the scan is acquired. This enables side-by-side visualization of the same location on the retina for each visit. OCT compares measurements from the current and prior visits to provide a thickness change map that our doctors determine the next steps for our patient. 3-D cubes and Advanced Visualization� can be used for pre-operative planning for VRI disorders. OCT can detect even the earliest signs of glaucoma before you would notice symptoms in your everyday life. This technology allows our doctors to start preventive treatment to help preserve your eyesight.

Corneal Topography
Corneal Topography is a non-invasive imaging technique for mapping the surface of the cornea. The cornea is a clear membrane that covers the front of the eye and is responsible for about 70 percent of the eye's focusing power. To a large extent, the shape of the cornea determines the visual ability of an otherwise healthy eye. A perfect eye has an evenly rounded cornea, but if the cornea is too flat, too steep, or unevenly curved, less than perfect vision results. The purpose of corneal topography is to produce a detailed description of the shape and power of the cornea. Using computerized imaging technology, the 3-D map produced by the corneal topographer aids our Doctors in the diagnosis, monitoring, and treatment of various visual conditions.

Visual Field Analysis
This test is a method of measuring an individual's scope of vision. This�subjective examination of the central and peripheral vision actually maps the field of vision of each eye individually. Visual field testing is�most frequently used to detect signs of optic nerve damage secondary to glaucoma, diabetic retinopathy, eyelid conditions such as ptosis or drooping of the eyelids, optic nerve disease, and diseases affecting the visual pathways within the brain. Visual field testing is generally covered by virtually all health-care insurance plans. Testing may be limited to one time per year for patients who are called glaucoma suspects, that is, likely to develop glaucoma in the future. Insurance plans usually allow two visual field tests per year for patients who have already been diagnosed with glaucoma.

Specular Microscopy (Endothelial Cell Count)
Specular microscopy topography is a rapid, non-invasive in-office test that evaluates the cells on the back layer of the cornea, the endothelial cells. These cells pump fluid out of the cornea to keep the cornea clear. Certain conditions such as endothelial dystrophy and Fuchs dystrophy which affect the endothelial cells can be evaluated with specular microscopy. This test can examine the size, shape and density of the cells. Serial measurements can be obtained to follow the health of these cells.

Proliferative Diabetic Retinopathy Theraphy
Proliferative diabetic retinopathy (PDR) is a serious complication of diabetes mellitus. In this situation, damage to the retinal blood vessels leads to the secretion of a substance called vascular endothelial growth factor (VEGF). VEGF causes abnormal blood vessels to grow on the surface of the retina and elsewhere in the eye. These vessels bleed easily and may also pull on the retina, causing retinal traction and detachment. They often grow to the point where they threaten vision even without the individual knowing that there is anything wrong.

A laser procedure called panretinal photocoagulation is the main treatment for proliferative diabetic retinopathy. In this approach, wide areas of the peripheral retina are treated in a nonspecific pattern of laser spots. This changes the blood vessel circulation in the eye and improves the delivery of oxygen to the retina. Panretinal photocoagulation reduces the amount of VEGF being produced in the eye, which therefore decreases the stimulus for new abnormal blood vessel growth. This treatment is quite extensive and often requires a retrobulbar anesthetic to prevent the laser from being too painful. One or more sessions may be needed to complete this treatment. Often patients have pain for a day or two after treatment, which is usually manageable with non-narcotic drugs. Vision is typically more blurred for a week or two after treatment, and then typically returns to baseline. It is not rare for bleeding to occur inside the eye after treatment because it takes several weeks for the regression of the neovascularization to occur. Some peripheral (side) vision and some night vision may be lost as a consequence of panretinal photocoagulation. Laser treatment for proliferative diabetic retinopathy is one of the most effective treatments in all of medicine. This therapy has saved the vision of many of our patients.

Maryland Eye Institute specializes in most innovative preventive tests, in order to promptly inform our patients if a surgery is required. Our Doctors will diligently study your individual case and recommend the greatest care options during your visit. We serve patients throughout the Washington metropolitan area. For the best eye care, please call us at 301-840-2208 and our staff will be happy to assist you.

Maryland Eye Institute 6 Montgomery Village Ave. Suite 103 Gaithersburg, MD 20879 Phone: (301) 840-2208 Fax: (301) 840-2210

© 2020 All content is the property of Maryland Eye Institute ™ & assoc. vendors. | DISCLAIMER | HIPAA
Website Powered and Developed by EyeVertise.com